Age-Stratified Ketone Dosing Matrix

Target: OXCT1 Composite Score: 0.452 Price: $0.50▲35.1% Citation Quality: Pending metabolic neuroscience Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

Composite: 0.452

Top 82% of 984 hypotheses

T3 Provisional

Single-source or model-inferred

Needs composite score ≥0.60 (current: 0.45) for Supported

D Mech. Plausibility 15% 0.30 Top 96%

F Evidence Strength 15% 0.20 Top 98%

B Novelty 12% 0.60 Top 80%

F Feasibility 12% 0.20 Top 96%

D Impact 12% 0.30 Top 98%

F Druggability 10% 0.20 Top 95%

F Safety Profile 8% 0.20 Top 97%

C Competition 6% 0.40 Top 92%

D Data Availability 5% 0.30 Top 94%

F Reproducibility 5% 0.20 Top 98%

Evidence

3 supporting | 2 opposing

Citation quality: 0%

Debates

1 session A

Avg quality: 0.80

Convergence

0.00 F 7 related hypothesis share this target

From Analysis:

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and how much ketosis provides benefit vs harm. The 'metabolic steal syndrome' hypothesis suggests timing could be critical but remains untested. Source: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (7)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Epigenetic Priming Ketone Protocol

Score: 0.882 | Target: HDAC2/HDAC3

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | Target: HMGCS2

Astrocyte-Neuron Metabolic Coupling Titration

Score: 0.704 | Target: BDH1

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | Target: IRAKM

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | Target: OXCT1

Circadian Epigenetic Ketone Synchronization Protocol

Score: 0.543 | Target: CLOCK/BMAL1

Glucose-Ketone Metabolic Switch Timing

Score: 0.531 | Target: GLUT1/GLUT3/MCT1/MCT2

→ View full analysis & all 8 hypotheses

Description

Neuroprotective ketone dosing should be inversely related to age due to declining endogenous ketone utilization capacity. Pediatric patients require lower doses (0.5-1.0 mM) due to higher baseline ketone utilization efficiency, while elderly patients need higher doses (2.0-4.0 mM) to overcome metabolic inflexibility and mitochondrial dysfunction.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 5 with PMID Validation: 0% 3 supporting / 2 opposing

✓ For (3)

No supporting evidence

No opposing evidence

(2) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 3CLIN 1GENE 1EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
Differential ketone metabolism confers intrinsic n…	Supporting	MECH	-	-	-	-	PMID:32304750	-
β-hydroxybutyrate alleviates brain aging through M…	Supporting	MECH	-	-	-	-	PMID:39216746	-
Age-related changes occur in diurnal ketogenesis p…	Supporting	MECH	-	-	-	-	PMID:25392021	-
Standard pharmacological principles suggest elderl…	Opposing	CLIN	-	-	-	-	PMID:36297110	-
OXCT1 succinylation and activation by SUCLA2 promo…	Opposing	GENE	Mol Cell	-	2025	-	PMID:39862868	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 3

Differential ketone metabolism confers intrinsic neuroprotection in immature brains during hypoxia-ischemia

PMID:32304750

β-hydroxybutyrate alleviates brain aging through MTA1 pathway activation

PMID:39216746

Age-related changes occur in diurnal ketogenesis patterns

PMID:25392021

✗ Opposing Evidence 2

Standard pharmacological principles suggest elderly patients should receive lower doses due to reduced hepatic…▼

Standard pharmacological principles suggest elderly patients should receive lower doses due to reduced hepatic and renal function, not higher doses as proposed

PMID:36297110

OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.

Mol Cell · 2025 · PMID:39862868

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-03 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Based on my research into ketone metabolism, neuroprotection, and the metabolic steal syndrome hypothesis, I'll generate novel therapeutic hypotheses for optimal timing and dosing of ketogenic interventions.

Novel Therapeutic Hypotheses for Ketogenic Neuroprotection

1. Circadian-Gated Ketone Window Hypothesis

Description: Ketone body utilization efficiency follows circadian rhythms, with optimal neuroprotective windows occurring during natural fasting periods (18:00-06:00). β-hydroxybutyrate administered during these periods maximizes mitochondrial efficiency while minimizing

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Based on my analysis of the available research, here is my critical evaluation of each hypothesis:

Critical Analysis of Ketogenic Neuroprotection Hypotheses

1. Circadian-Gated Ketone Window Hypothesis

Specific Weaknesses:

The PMID:17126577 citation is vague and doesn't specifically support circadian variations in OXCT1 expression or ketone utilization efficiency
No direct evidence provided for the claimed 18:00-06:00 optimal window
Assumption that circadian energy metabolism variations translate to ketone-specific therapeutic windows is unsubstantiated

**Counter-Eviden

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Druggability Assessment for Ketogenic Neuroprotection Hypotheses

Based on my analysis of the target proteins and therapeutic landscape, here's a comprehensive assessment of the practical feasibility for each surviving hypothesis:

1. Circadian-Gated Ketone Window Hypothesis (Target: OXCT1)

Revised Confidence: 0.35

Druggability Assessment

POOR DRUGGABILITY - OXCT1 is a mitochondrial matrix enzyme that catalyzes CoA transfer reactions. The active site is highly conserved and essential for cellular metabolism, making selective modulation extremely challenging without disrupting

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 35.1%

Volatility

Medium

0.0223

Events (7d)

⚡ Price Movement Log Recent 9 events

	Event	Price	Change	Source	Time
💬	Debate Round	$0.467	▼ 5.6%	market_dynamics	2026-04-17 09:22
📊	Score Update	$0.495	▼ 12.5%	market_dynamics	2026-04-17 09:13
💬	Debate Round	$0.566	▲ 71.1%	market_dynamics	2026-04-17 08:23
📊	Score Update	$0.331	▼ 0.8%	market_dynamics	2026-04-17 08:06
💬	Debate Round	$0.333	▼ 36.1%	market_dynamics	2026-04-17 06:14
📊	Score Update	$0.522	▲ 41.4%	market_dynamics	2026-04-17 04:15
📄	New Evidence	$0.369	▼ 1.6%	market_dynamics	2026-04-17 02:26
📄	New Evidence	$0.375	▼ 18.1%	market_dynamics	2026-04-16 22:50
📄	New Evidence	$0.458		market_dynamics	2026-04-16 21:33

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

Endocrine journal (2015) · PMID:25392021

No extracted figures yet

Differential glucose and beta-hydroxybutyrate metabolism confers an intrinsic neuroprotection to the immature brain in a rat model of neonatal hypoxia ischemia.

Experimental neurology (2021) · PMID:32304750

No extracted figures yet

Toxicity Investigations of (R)-3-Hydroxybutyrate Glycerides In Vitro and in Male and Female Rats.

Nutrients (2022) · PMID:36297110

No extracted figures yet

β-Hydroxybutyrate alleviates brain aging through the MTA1 pathway in D-galactose injured mice.

European journal of pharmacology (2024) · PMID:39216746

No extracted figures yet

Paper:39862868

No extracted figures yet

📓 Linked Notebooks (1)

📓 What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? - Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-03-gap-debate-20260403-222618-2709aad9. While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and ho …

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

KG Entities (14)

BDH1 GLUT1/GLUT3/MCT1/MCT2 HDAC2/HDAC3 HMGCS2 IRAKM OXCT1 h-17a2da3f h-404bab00 h-6df1bc66 h-9d4571a7 h-a1d97415 h-a947032c h-d7212534 metabolic_neuroscience

Related Hypotheses

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | metabolic neuroscience

Epigenetic Priming Ketone Protocol

Score: 0.882 | metabolic neuroscience

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | metabolic neuroscience

Astrocyte-Neuron Metabolic Coupling Titration

Score: 0.704 | metabolic neuroscience

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | metabolic neuroscience

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (13 edges)

associated with (6)

HDAC2/HDAC3 → metabolic_neuroscience

HMGCS2 → metabolic_neuroscience

BDH1 → metabolic_neuroscience

IRAKM → metabolic_neuroscience

OXCT1 → metabolic_neuroscience

...and 1 more

targets (7)

h-d7212534 → HDAC2/HDAC3

h-6df1bc66 → HMGCS2

h-17a2da3f → BDH1

h-a1d97415 → IRAKM

h-9d4571a7 → OXCT1

...and 2 more

Mechanism Pathway for OXCT1

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    h_9d4571a7["h-9d4571a7"] -->|targets| OXCT1["OXCT1"]
    h_404bab00["h-404bab00"] -->|targets| OXCT1_1["OXCT1"]
    OXCT1_2["OXCT1"] -->|associated with| metabolic_neuroscience["metabolic_neuroscience"]
    style h_9d4571a7 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1 fill:#ce93d8,stroke:#333,color:#000
    style h_404bab00 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1_1 fill:#ce93d8,stroke:#333,color:#000
    style OXCT1_2 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 OXCT1 — Search for structure Click to search RCSB PDB

🔍 Searching RCSB PDB for OXCT1 structures...

Querying Protein Data Bank API

Source Analysis

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

metabolic neuroscience | 2026-04-03 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)